Flucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: a randomised controlled trial
Open Access
- 1 May 2005
- journal article
- clinical trial
- Published by BMJ in Emergency Medicine Journal
- Vol. 22 (5), 342-346
- https://doi.org/10.1136/emj.2004.019869
Abstract
Objective: To determine whether using intravenous benzylpenicillin in addition to intravenous flucloxacillin would result in a more rapid clinical response in patients with lower limb cellulitis. Methods: This was a randomised controlled trial set in an inner city teaching hospital, comprising 81 patients with lower limb cellulitis requiring intravenous antibiotics. The main outcome measure was the mean number of doses of antibiotic required until clinical response. Results: The mean number of doses required was 8.47 (95% confidence interval (CI) 7.09 to 9.86) in the benzylpenicillin and flucloxacillin combined group. In the flucloxacillin only group it was 8.71 doses (95% CI 6.90 to 10.5), a mean difference of −0.24 doses (95% CI −2.48 to 2.01, p = 0.83). Other markers of treatment efficacy showed no difference between groups at review the following day; temperature decrease (mean difference −0.07°C, 95% CI −0.76 to 0.62, p = 0.84), or diameter decrease of affected area (mean difference −34 mm, 95% CI −99 to 31, p = 0.30). Patient subjective assessments were also similar between the different drug regimen; improvement on a visual analogue scale of pain/discomfort from admission to first review (mean difference 10 mm, 95% CI −12.6 to 14.2, p = 0.91) and on second review (mean difference 15 mm, 95% CI −18.6 to 21.6, p = 0.88). Patient overall subjective feelings of improvement on first review (p = 0.32) and on second review (p = 0.64) were also similar. Conclusions: This study provides no evidence to support the addition of intravenous benzylpenicillin to intravenous flucloxacillin in the treatment of lower limb cellulitis.Keywords
This publication has 25 references indexed in Scilit:
- Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infectionsClinical Therapeutics, 2002
- Once‐Daily Intravenous Cefazolin Plus Oral Probenecid Is Equivalent to Once‐Daily Intravenous Ceftriaxone Plus Oral Placebo for the Treatment of Moderate‐to‐Severe Cellulitis in AdultsClinical Infectious Diseases, 2002
- Cellulitis and erysipelas.2002
- Management of lower leg cellulitisClinical Medicine, 2002
- ED management of cellulitis: A review of five urban centersThe American Journal of Emergency Medicine, 2001
- The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis.Journal of Antimicrobial Chemotherapy, 2001
- [Diagnostic criteria for erysipelas].2001
- Clinafloxacin versus Piperacillin-Tazobactam in Treatment of Patients with Severe Skin and Soft Tissue InfectionsAntimicrobial Agents and Chemotherapy, 2001
- Cost-Effectiveness of Blood Cultures for Adult Patients with CellulitisClinical Infectious Diseases, 1999
- Lesson of the week: Importance of distinguishing between cellulitis and varicose eczema of the legBMJ, 1999